Tylenol exposure in pregnancy draws fresh scrutiny as the latest evidence links prenatal exposure to reproductive changes in daughters.
Lung disease pipeline advances as a cancer combo and PH-ILD drug deliver strong survival, pressure, and functional gains.
Sun Pharma wins investment-grade ratings as its USD 11.75-billion Organon deal strengthens scale, geographic reach and growth opportunities.
Ayurveda seeks to bridge tradition and modern medicine through preventive healthcare, evidence-based research, innovation, and integrative care.
Biocon’s Brazil pact could lower pertuzumab costs for public patients by expanding biosimilar access and supporting local manufacturing.
India’s peptide API race heats up as HRV Pharma commits Rs 150 crore to expand synthetic peptide and high-potency oncology API capacity.
The obesity drug market swings between big wins and bigger doubts as new trial results, rising sales and treatment limits reshape the industry.
Roche Pharma India announced the winners of the third edition of the Leading Engagements to Advance Patient Care (LEAP) program.
Chronic care and GLP-1 therapeutics are reshaping the Indian Pharmaceutical Market as long-term therapies drive growth, demand, and investment.
Novartis India has approved a Rs 1,250 crore deal to acquire Pfizer's Minipress and Minipress trademarks in India. The deal also includes certain related intellectual property rights. The company’s board approved the transaction...
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")